Universitätsklinikum Schleswig-Holstein, Campus Kiel

Kiel, Schleswig-Holstein 24105

1 studies enrolling now · 3 studies all time

What they study most

Advanced Melanoma, HER2-positive Breast Cancer, Idiopathic Pulmonary Fibrosis

Studies at this site

• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. — Recruiting now
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling